EXAS
Exact Sciences Corporation
Company Overview
| Mkt Cap | $11.98B | Price | $66.60 |
| Volume | 3.15M | Change | +2.95% |
| P/E Ratio | -11.6 | Open | $64.90 |
| Revenue | $2.8B | Prev Close | $64.69 |
| Net Income | $-1.0B | 52W Range | $38.81 - $72.83 |
| Div Yield | N/A | Target | $71.42 |
| Overall | 66 | Value | 60 |
| Quality | 50 | Technical | 90 |
No chart data available
Stock Overview
Updated DailyExact Sciences Corporation (EXAS) is a leading Healthcare company in the Diagnostics & Research industry, currently trading at $66.60 with a market capitalization of $11.98 billion. The stock is trading near its 52-week highs, indicating strong momentum, demonstrating average quality indicators with a MarketXLS quality score of 50.
Today's trading session shows EXAS with a volume of 3.15 million shares. The stock opened up 0.32% from yesterday's close of $64.69. Current analyst estimates project earnings of $0.38 per share for this year, with next year targeting $1.33.
EXAS demonstrates very strong technical momentum based on technical analysis. The company trades on the NSC exchange and operates alongside industry peers including MYGN, IVC, ATRS, VCYT, BIOC.
Key investment considerations for EXAS include solid overall investment characteristics. The company offers a dividend yield of NA% and analyst price targets suggest potential upside of 7.2%. The stock shows fair valuation metrics based on valuation analysis.
Analysis generated on November 3, 2025 at 09:08 PM
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | EXAS | $66.60 | +3.0% | 3.15M |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |
Get Exact Sciences Corporation Data in Excel
Stream real-time data directly to your spreadsheets
BUY NOW